SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-098497
Filing Date
2013-03-08
Accepted
2013-03-08 16:01:03
Documents
10
Period of Report
2013-04-30
Effectiveness Date
2013-03-08

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d489296ddef14a.htm DEF 14A 1079751
2 GRAPHIC g489296g00t53.jpg GRAPHIC 47284
3 GRAPHIC g489296g11g23.jpg GRAPHIC 7027
4 GRAPHIC g489296g21r83.jpg GRAPHIC 9525
5 GRAPHIC g489296g27c93.jpg GRAPHIC 160421
6 GRAPHIC g489296g36j76.jpg GRAPHIC 5342
7 GRAPHIC g489296g41w91.jpg GRAPHIC 11965
8 GRAPHIC g489296g53z85.jpg GRAPHIC 11456
9 GRAPHIC g489296g54d30.jpg GRAPHIC 62195
10 GRAPHIC g489296g73x03.jpg GRAPHIC 11815
  Complete submission text file 0001193125-13-098497.txt   1532663
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Filer) CIK: 0000850693 (see all company filings)

IRS No.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-10269 | Film No.: 13677454
SIC: 2834 Pharmaceutical Preparations